🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Julia Krzykalla

Boehringer Ingelheim (Germany)

ORCID: 0000-0002-5242-9824

Also affiliated with Boehringer Ingelheim (Australia)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results”.

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results

Leukemia(2021)10.1038/s41375-021-01323-0

N/A

2.1DataRank · unranked

90 citations

Ling Du, Tamara J. Luck, Axel Benner, Julia Krzykalla, Insa Gathmann +25 more

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial

Leukemia(2022)10.1038/s41375-022-01650-w

N/A

0DataRank · unranked

39 citations

Maral Saadati, Lars Bullinger, Richard A. Larson, Tiziana Ottone, Sergio Amadori +18 more

Design of a phase II randomised, double-blind, placebo-controlled, dose-finding trial of BI 1819479 in patients with idiopathic pulmonary fibrosis

ERJ Open Research(2025)10.1183/23120541.00973-2025

N/A

0DataRank · unranked

0 citations

Francesco Bonella, Haruyuki Ishii, Joyce Lee, Elisabetta Renzoni, Sandra Hadl +5 more